These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6734036)

  • 81. [Effect of verapamil on urinary K-excretion].
    Haas H
    Arzneimittelforschung; 1972 Jul; 22(7):1126-38. PubMed ID: 4678119
    [No Abstract]   [Full Text] [Related]  

  • 82. Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls.
    Gengo FM; Fagan SC; Krol G; Bernhard H
    Br J Clin Pharmacol; 1987 Jan; 23(1):47-53. PubMed ID: 3814462
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potassium and magnesium retaining potency and efficacy of triamterene and analogues in conscious saline-loaded rats.
    Priewer H; Ullrich F; Mutschler E
    Magnes Res; 1996 Mar; 9(1):33-40. PubMed ID: 8819092
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Determination of the diuretic triamterene in the plasma and urine of humans by high-performance liquid chromatography.
    Brodie RR; Chasseaud LF; Taylor T; Walmsley LM
    J Chromatogr; 1979 Dec; 164(4):527-33. PubMed ID: 541431
    [No Abstract]   [Full Text] [Related]  

  • 85. Deconjugation of p-hydroxytriamterene sulphate in the rat.
    Muirhead MR; Somogyi AA; Lloyd C; Bochner F
    Xenobiotica; 1989 Jun; 19(6):655-60. PubMed ID: 2763574
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The identification and quantitation of triamterene in blood and urine from a fatal aircraft accident victim.
    White V; Canfield DV; Hordinsky J
    J Anal Toxicol; 1994; 18(1):52-3. PubMed ID: 8127086
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Disposition kinetics and concentration-effect relationship of metipranolol in patients with cirrhosis and healthy subjects.
    Janků I; Perlík F; Tkaczyková M; Brodanová M
    Eur J Clin Pharmacol; 1992; 42(3):337-40. PubMed ID: 1349528
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Abnormal urinary sediment in patients on triamterene.
    Fairley KF; Birch DF; Haines I
    Lancet; 1983 Feb; 1(8321):421-2. PubMed ID: 6130414
    [No Abstract]   [Full Text] [Related]  

  • 89. Spurious elevation of apparent lactate dehydrogenase activity caused by triamterene.
    Chainuvati T; Harinasuta U; Zimmerman HJ
    Clin Chem; 1973 Oct; 19(10):1202-4. PubMed ID: 4741963
    [No Abstract]   [Full Text] [Related]  

  • 90. Rapid method for the determination of the diuretic triamterene and its metabolites in plasma and urine by high-performance liquid chromatography.
    Swart KJ; Botha H
    J Chromatogr; 1987 Jan; 413():315-9. PubMed ID: 3558684
    [No Abstract]   [Full Text] [Related]  

  • 91. Rapid assay for triamterene in plasma.
    Sved S; Sertié JA; McGilveray IJ
    J Chromatogr; 1979 Mar; 162(3):474-9. PubMed ID: 528616
    [No Abstract]   [Full Text] [Related]  

  • 92. Interference of triameterene with cortisol determination in urine.
    Radó JP; Végh L; Sawinsky I
    Horm Metab Res; 1974 Sep; 6(5):429-30. PubMed ID: 4423766
    [No Abstract]   [Full Text] [Related]  

  • 93. Triamterene-induced nephrolithiasis.
    Ettinger B; Weil E; Mandel NS; Darling S
    Ann Intern Med; 1979 Nov; 91(5):745-6. PubMed ID: 496113
    [No Abstract]   [Full Text] [Related]  

  • 94. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
    Verbeeck RK; Horsmans Y
    Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Guide to drug dosage in hepatic disease.
    Bass NM; Williams RL
    Clin Pharmacokinet; 1988 Dec; 15(6):396-420. PubMed ID: 3072141
    [No Abstract]   [Full Text] [Related]  

  • 98. Clinical pharmacokinetics in patients with liver disease.
    McLean AJ; Morgan DJ
    Clin Pharmacokinet; 1991 Jul; 21(1):42-69. PubMed ID: 1914341
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Triamterene kinetics and dynamics in cirrhosis.
    Villeneuve JP; Rocheleau F; Raymond G
    Clin Pharmacol Ther; 1984 Jun; 35(6):831-7. PubMed ID: 6734036
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.